Innate Pharma SA
Change company Symbol lookup
Select an option...
IPHYF Innate Pharma SA
BAC Bank of America Corp
AZN AstraZeneca PLC
CLZNY Clariant AG
CARR Carrier Global Corp
KBH KB Home
SMIT Schmitt Industries Inc
OOMA Ooma Inc
SEDG Solaredge Technologies Inc
CELH Celsius Holdings Inc
Go


Based in France
Company profile

Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Closing Price
$5.45
Day's Change
0.27 (5.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.49
Day's Low
5.45
Volume
(Heavy Day)
Volume:
600

10-day average volume:
975
600
  • Prev Close
    5.18
  • Today's Open
    5.49
  • Day's Range
    5.45-5.49
  • Avg Vol (10-day)
    975
  • Last (time)
    10:46a ET 11/27/20
  • Last (size)
    100
  • 52-Wk Range
    3.70 - 8.12
    LowHigh
  • (01/02/20 - 10/28/20)
    47.30%
  • 102.0%
  • Market Cap
    430.3M
  • Shares Outstanding
    79.0M
  • -0.62
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • --
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.